biuro@scopefluidics.com +48 22 376 21 14

About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact

biuro@scopefluidics.com +48 22 376 21 14

About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact

biuro@scopefluidics.com +48 22 376 21 14

RAPORT ESPI 32/2021 | 30-09-2021 | Wyniki przedrejestracyjnych testów walidacyjnych systemu BacterOMIC

Previous PostRAPORT ESPI 31/2021 | 30-09-2021 | Zawiadomienie o zmianie stanu posiadania akcji SpółkiNext PostRAPORT ESPI 33/2021 | 07-10-2021 | Zawarcie umowy warrantowej i dalsze działania dotyczące finansowania od EBI

0Shares

Related Posts

Scope Fluidics Launches Fellowship Program for Young Scientists with Project Budgets of up to PLN 1 Million

Historic Deal Completed, Strategic Innovation Now Advancing – Scope Fluidics Post 2024

European Patent Granted to Bacteromic

CONTACT US

Tel. +48 22 376 21 14
Email: biuro@scopefluidics.com

Address

Ogrodowa 58
9th floor
00-876 Warsaw

KRS: 0000668408

NIP: 527-264-59-89

REGON: 142-754-170

LEI: 259400EUNFX4E2BEHU15

Company registered in the District Court for the Capital City of Warsaw in Warsaw, XII Commercial Division of the National Court Register.

Share capital: PLN 272 593,00 fully paid up

Bank Account Number: 03 2490 0005 0000 4520 3046 2136

Terms of use

Cookies Policy

Information clause

Whistleblower Protection

Scope Fluidics 2021 ® All rights reserved